Susquehanna Fundamental Investments’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-43,960
| Closed | -$227K | – | 1405 |
|
|
2021
Q3 | $227K | Sell |
43,960
-75,790
| -63% | -$391K | ﹤0.01% | 1497 |
|
|
2021
Q2 | $510K | Sell |
119,750
-39,940
| -25% | -$170K | 0.01% | 1157 |
|
|
2021
Q1 | $848K | Sell |
159,690
-12,060
| -7% | -$64K | 0.01% | 951 |
|
|
2020
Q4 | $926K | Buy |
171,750
+68,415
| +66% | +$369K | 0.02% | 888 |
|
|
2020
Q3 | $825K | Buy |
103,335
+39,135
| +61% | +$312K | 0.02% | 707 |
|
|
2020
Q2 | $643K | Buy |
+64,200
| New | +$643K | 0.03% | 545 |
|